In a meta-analysis including 1,163 patients from 19 studies, p53 expression was significantly higher in high-/intermediate-risk GISTs compared to low-/very-low-risk GIST and correlated with a poor prognosis (31). Here, TP53 is linked to gastrointestinal stromal tumor.